The lysyl oxidase family exhibits aberrant gene and protein expression in a number of solid tumors and its activity is closely associated with the development of tumor desmoplasia and, as a result, the family has emerged as a potential antistromal target in cancer13. The gene discussed is LOX; the disease is neoplasm.